In our study investigating the mineral metabolism in end-stage renal disease, it was revealed that the sKl, 1,25(OH)2D and Ca levels decreased and FGF23, PTH and P levels increased in haemodialysis patients. This evidence concerns the gene PTH and stage 5 chronic kidney disease.